Literature DB >> 902458

Glutethimide and 4-OH glutethimide: pharmacokinetics and effect on performance in man.

J W Crow, P Lain, F Bochner, D W Shoeman, D L Azarnoff.   

Abstract

The relationship between the plasma concentration of glutethimide (G) and the change from baseline of the standard error of the mean (deltaSDE) of a tracking test was determined in 7 volunteers. There was excellent positive correlation (r = 0.91) between log G and log deltaSDE and good correlation between log G and deltaSDE (r = 0.77). The metabolite, 4 hydroxyglutethimide, did not contribute significantly to the effect of G administered in therapeutic doses. No trend in performance versus level was found with 5 other tests (finger tapping, card sorting, digit substitution, subtraction, and subjective perception of drowsiness). Although the numbers were small, when the volunteers were divided into smokers (3) and nonsmokers (4) G decreased tracking ability to a greater extent in smokers than in nonsmokers.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 902458     DOI: 10.1002/cpt1977224458

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  4 in total

Review 1.  Role of tobacco smoking in pharmacokinetics.

Authors:  W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1978-02

Review 2.  Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics.

Authors:  L G Miller
Journal:  Clin Pharmacokinet       Date:  1989-08       Impact factor: 6.447

3.  Lack of correlation between plasma 4-hydroxyglutethimide and severity of coma in acute glutethimide poisoning. A case report and brief review of the literature.

Authors:  S C Curry; J M Hubbard; R Gerkin; B Selden; P J Ryan; R Meinhart; D Hagner
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

Review 4.  Pharmacokinetics of drug overdose.

Authors:  J Rosenberg; N L Benowitz; S Pond
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.